Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

26.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Val109 and Ile170 contribute to channel function in Guillardia theta-derived anion channelrhodopsins.

Scientific reports·2026
Same author

Pyrroloquinoline Quinone Protects Against Light-Induced Retinal Damage in Association with the Suppression of c-Fos Signalling.

International journal of molecular sciences·2026
Same author

Direct reprogramming of Müller glia into photoreceptors via multiple transcription factors and small molecules: molecular mechanisms and transcriptomic analysis.

In vitro cellular & developmental biology. Animal·2026
Same author

A Simplified Tea Ceremony Experience for Palliative Care Staff: A Feasibility and Acceptability Study.

Cureus·2026
Same author

Engineering Immortalized Bovine Granulosa Cells Using a Triple-Gene Approach: Mutant CDK4, Cyclin D1, and TERT.

Cell biology international·2026
Same author

Mitochondrial calpain-1 truncates ATP synthase beta subunit.

Biochemical and biophysical research communications·2025

Related Experiment Video

Updated: Nov 23, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.8K

Optogenetics-Mediated Gene Therapy for Retinal Diseases.

Hiroshi Tomita1, Eriko Sugano2

  • 1Laboratory of Visual Neuroscience, Department of Chemistry and Biological Sciences, Faculty of Science and Engineering, Iwate University, Morioka, Iwate, Japan. htomita@iwate-u.ac.jp.

Advances in Experimental Medicine and Biology
|January 5, 2021
PubMed
Summary

Gene therapy using channelrhodopsins offers hope for blindness caused by retinal diseases like retinitis pigmentosa. This approach aims to restore vision by genetically modifying neurons to respond to light.

Keywords:
Gene therapyPhotoreceptor degenerationRetinaRetinitis pigmentosa

More Related Videos

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.6K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

33.8K

Related Experiment Videos

Last Updated: Nov 23, 2025

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.8K
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.6K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

33.8K

Area of Science:

  • Neuroscience
  • Genetics
  • Ophthalmology

Background:

  • The visual system relies on a complex pathway involving photoreceptor, second-order, and ganglion cells to transmit light signals to the brain.
  • Genetic mutations, particularly single-nucleotide mutations, can disrupt this pathway, leading to blindness.
  • Retinitis pigmentosa and age-related macular degeneration are severe retinal diseases causing significant visual impairment.

Purpose of the Study:

  • To review the potential of gene therapy using channelrhodopsins for treating retinal diseases.
  • To specifically discuss mVChR1-mediated gene therapy for retinitis pigmentosa.
  • To explore the future applications of optogenetic genes in managing retinal conditions.

Main Methods:

  • Review of existing literature on channelrhodopsins and gene therapy.
  • Focus on mVChR1 (a cation channelrhodopsin) and its application in retinitis pigmentosa models.
  • Discussion of optogenetic gene therapy principles in the context of retinal function.

Main Results:

  • Channelrhodopsins, acting as light-gated ion channels, can be introduced into retinal neurons.
  • mVChR1-mediated gene therapy shows promise for restoring light sensitivity in photoreceptor-deficient retinas.
  • Optogenetic approaches offer a potential strategy to bypass damaged retinal circuitry.

Conclusions:

  • Gene therapy with channelrhodopsins presents a viable therapeutic strategy for inherited retinal diseases.
  • mVChR1-mediated gene therapy is a promising avenue for treating retinitis pigmentosa.
  • Optogenetics holds significant potential for future treatments of various retinal degenerative diseases.